fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

New Sheba Study Offers an Alternative to Non-invasive Colonoscopy

non-invasive colonoscopy
By helping detect inflammation and other conditions using stool samples, a joint Sheba and Weizmann Institute of Science research can prove key to avoiding the invasive procedure and offer an alternative non-invasive colonoscopy instead.

Colonoscopies have become an essential tool in detecting and preventing deaths. In fact, one study found that the procedure reduces the risk of bowel cancer by up to 45 percent. But cancer isn’t the only reason a colonoscopy might be ordered. The procedure is also used to detect bowel inflammation. While colonoscopies can be an essential part of diagnosis, they often require hours of prep time, and general anesthesia, and are very invasive and uncomfortable.

However, new research promises many patients an alternative in the form of a non-invasive colonoscopy. Working with the Weizmann Institute of Science, Sheba’s Dr. Bella Ungar led a study that used advanced techniques, including RNA sequencing, to detect inflammation in the bowel by analyzing fecal samples – which could prove a better, less invasive way to pinpoint issues and determine the best course of treatment.

Dr. Ungar’s team compared samples taken from the participants diagnosed with inflammatory bowel disease with those of 30 healthy patients. Results showed that samples from individuals with IBD contained four types of immune-related cells that are often associated with and indicate the presence of inflammation.

In addition to replacing invasive screenings, the new research could help medical professionals diagnose and treat Crohn’s disease and ulcerative colitis. Researchers are also investigating how it can be used to detect pancreatic cancer.

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More